The FDA announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people who have laboratory-confirmed previous dengue infection and who live in endemic areas. PRODUCT DESCRIPTION: Dengvaxia is a live, attenuated, tetravalent, chimeric virus vaccine, containing the […]

Mexico unveiled the world’s first approved dengue vaccine. The approval followed two years of clinical trials worldwide on more than 40,000 patients ! According to the World Health Organisation (WHO), “nearly 40 percent of the world’s population (3.9 billion people) is at risk of contracting dengue.” Around 400 million people in more than 128 countries […]